ESR1 and breast cancer: A gene expression profile of BC stroma, characterized as activated by fibrosis and motility genes, has an unfavorable prognostic effect on survival of ER+ BC patients, reaching statistical significance in hormone-treated patients, in contrast to inactive stroma characterized by expression of claudin and adhesion molecule genes [130].